Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6340-03-0

Post Buying Request

6340-03-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6340-03-0 Usage

Description

1H-Benzimidazole-1-ethanol(9CI) is a chemical compound characterized by the molecular formula C9H9N2O. It is a benzimidazole derivative, featuring a benzene ring fused to an imidazole ring with an ethanol group attached. 1H-Benzimidazole-1-ethanol(9CI) exhibits potential biological and pharmacological activities, making it a promising candidate for the synthesis of various pharmaceutical compounds. Its properties and activity suggest potential applications in the development of antiviral, antifungal, and anticancer agents, as well as other therapeutic uses. 1H-Benzimidazole-1-ethanol(9CI) is a valuable compound for further research and development in medicinal chemistry and drug discovery.

Uses

Used in Pharmaceutical Synthesis:
1H-Benzimidazole-1-ethanol(9CI) is used as a key intermediate in the synthesis of various pharmaceutical compounds due to its unique structure and potential biological activities.
Used in Antiviral Applications:
1H-Benzimidazole-1-ethanol(9CI) is used as an antiviral agent for its potential to inhibit viral replication and reduce the severity of viral infections.
Used in Antifungal Applications:
1H-Benzimidazole-1-ethanol(9CI) is used as an antifungal agent to combat fungal infections by disrupting the fungal cell wall and inhibiting fungal growth.
Used in Anticancer Applications:
1H-Benzimidazole-1-ethanol(9CI) is used as an anticancer agent for its potential to target and inhibit the growth of cancer cells, making it a promising candidate for the development of novel cancer therapies.
Used in Medicinal Chemistry Research:
1H-Benzimidazole-1-ethanol(9CI) is used as a valuable compound in medicinal chemistry research for its potential to contribute to the discovery and development of new drugs with diverse therapeutic applications.
Used in Drug Discovery:
1H-Benzimidazole-1-ethanol(9CI) is used in drug discovery processes to identify and optimize new drug candidates with improved efficacy, safety, and selectivity for various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 6340-03-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,4 and 0 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 6340-03:
(6*6)+(5*3)+(4*4)+(3*0)+(2*0)+(1*3)=70
70 % 10 = 0
So 6340-03-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H10N2O/c12-6-5-11-7-10-8-3-1-2-4-9(8)11/h1-4,7,12H,5-6H2

6340-03-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(benzimidazol-1-yl)ethanol

1.2 Other means of identification

Product number -
Other names 2-benzimidazolylethan-1-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6340-03-0 SDS

6340-03-0Relevant articles and documents

Synthesis, crystal structures, spectral investigations, conformational analysis and DFT studies of N- heterocyclic carbene precursors

Erdemir, Fato?,Celepci, Duygu Barut,Akta?, Ayd?n,G?k, Yetkin

, (2020)

Three new 2-hydroxyethyl substituted N-heterocyclic carbene (NHC) precursors were synthesized in this study. These NHC precursors were prepared from 1-(alkyl/aryl)benzimidazole and alkyl halides. Their structural characterizations were performed by elemental analysis, 1H NMR, 13C NMR, FT–IR and UV–Vis spectroscopy and single-crystal X-ray diffraction. The spectral features were also characterized by Density Functional Theory (DFT) at B3LYP/Lanl2dz//6-31G++(d,p) basis set. Two most stable conformers belonging to the compounds were found by potential energy surface (PES) scan, and the theoretical ground-state geometries were investigated. Among these conformers, the geometry of the conformer-I for all compounds matches almost well with the experimental results. 1H and 13C NMR chemical shifts were calculated with GIAO approach and compared to the observed ones. Detailed vibrational assignments of the wavenumbers of the conformers were carried out based on the potential energy distribution (PED). Natural bond orbital (NBO) analysis was used to analyze the stability of the molecules arising from hyperconjugative interactions and charge delocalization. The HOMO–LUMO energy gap of the stable conformers was calculated for comparing their chemical reactivity behavior. Molecular electrostatic potential (MEP) diagrams were used to get information about ?the size, shape, charge density distribution and site of chemical reactivity of each stable conformer. The 3D Hirshfeld surfaces and the associated 2D fingerprint plots were also carried out to obtain an insight into the behavior of the interactions in the compounds.

Synthesis of N-heterocyclic nitrenium (NHN) ions and related donor systems: Coordination with d10-metal ions

Yadav, Sangeeta,Deka, Rajesh,Raju, Saravanan,Singh, Harkesh B.

, p. 269 - 277 (2019/02/05)

The synthesis of three new NNN- and CNC type N-heterocyclic nitrenium (NHN) ion based pincer ligands is reported from 1,3-di-(2′-bromoethyl)-triazolium bromide (5). The reaction of 5 with ammonium hexafluorophosphate followed by two equivalent of pyrrolid

A2 ADENOSINE RECEPTOR AGONISTS

-

Page/Page column 28, (2009/03/07)

Disclosed are AZB adenosine receptor (AR) agonists of formula (I), in which R1, R2, R3, R4, Z, and n are defined herein. The invention also provides compositions comprising at least one compound of formula I and methods of use thereof, for example, in the treatment of septic shock, cystic fibrosis, restenosis, erectile dysfunction, inflammation, myocardial ischemia, and reperfusion injury.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6340-03-0